English
简体中文
Total: £ 56.28
Published Date: 2025-12-23 | Pages: 94 | Tables: 92 | Pharma & Healthcare
The global market for Monkeypox Virus Monoclonal Antibody was valued at US$ 1377 million in the year 2024 and is projected to reach a revised size of US$ 2528 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus.
North American market for Monkeypox Virus Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monkeypox Virus Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Monkeypox Virus Monoclonal Antibody include ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, Absolute Antibody, Creative Biolabs, Sanyoubio, Cnpair, Vazyme, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Monkeypox Virus Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Virus Monoclonal Antibody.
The Monkeypox Virus Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monkeypox Virus Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Virus Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ProteoGenix
ACROBiosystems
Creative Diagnostics
Novus Biologicals, LLC
Merck Group
Absolute Antibody
Creative Biolabs
Sanyoubio
Cnpair
Vazyme
Sinobiological
Segment by Type
Purity>90%
Purity>95%
Others
Segment by Application
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monkeypox Virus Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monkeypox Virus Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Monkeypox Virus Monoclonal Antibody Market Overview
1.1 Product Definition
1.2 Monkeypox Virus Monoclonal Antibody by Type
1.2.1 Global Monkeypox Virus Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity>90%
1.2.3 Purity>95%
1.2.4 Others
1.3 Monkeypox Virus Monoclonal Antibody by Application
1.3.1 Global Monkeypox Virus Monoclonal Antibody Market Value by Application (2024 VS 2031)
1.3.2 Diagnostic Laboratories
1.3.3 Research and Academic Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Global Monkeypox Virus Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Monkeypox Virus Monoclonal Antibody Revenue 2020-2031
1.4.2 Global Monkeypox Virus Monoclonal Antibody Sales 2020-2031
1.4.3 Global Monkeypox Virus Monoclonal Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Monkeypox Virus Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Monkeypox Virus Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Product Type & Application
2.7 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Date of Enter into This Industry
2.8 Global Monkeypox Virus Monoclonal Antibody Market Competitive Situation and Trends
2.8.1 Global Monkeypox Virus Monoclonal Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Monkeypox Virus Monoclonal Antibody Players Market Share by Revenue
2.8.3 Global Monkeypox Virus Monoclonal Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Monkeypox Virus Monoclonal Antibody Market Scenario by Region
3.1 Global Monkeypox Virus Monoclonal Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2020-2031
3.2.1 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2020-2025
3.2.2 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2026-2031
3.3 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2020-2031
3.3.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2020-2025
3.3.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2026-2031
3.4 North America Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Monkeypox Virus Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2031)
3.4.3 North America Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Monkeypox Virus Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2031)
3.5.3 Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Monkeypox Virus Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Monkeypox Virus Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2031)
3.7.3 Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Monkeypox Virus Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2031)
4.1.1 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2025)
4.1.2 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2026-2031)
4.1.3 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2020-2031)
4.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2020-2031)
4.2.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2020-2025)
4.2.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2026-2031)
4.2.3 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Monkeypox Virus Monoclonal Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2031)
5.1.1 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2025)
5.1.2 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2026-2031)
5.1.3 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2020-2031)
5.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2020-2031)
5.2.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2020-2025)
5.2.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2026-2031)
5.2.3 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Monkeypox Virus Monoclonal Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ProteoGenix
6.1.1 ProteoGenix Company Information
6.1.2 ProteoGenix Description and Business Overview
6.1.3 ProteoGenix Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ProteoGenix Monkeypox Virus Monoclonal Antibody Product Portfolio
6.1.5 ProteoGenix Recent Developments/Updates
6.2 ACROBiosystems
6.2.1 ACROBiosystems Company Information
6.2.2 ACROBiosystems Description and Business Overview
6.2.3 ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ACROBiosystems Monkeypox Virus Monoclonal Antibody Product Portfolio
6.2.5 ACROBiosystems Recent Developments/Updates
6.3 Creative Diagnostics
6.3.1 Creative Diagnostics Company Information
6.3.2 Creative Diagnostics Description and Business Overview
6.3.3 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product Portfolio
6.3.5 Creative Diagnostics Recent Developments/Updates
6.4 Novus Biologicals, LLC
6.4.1 Novus Biologicals, LLC Company Information
6.4.2 Novus Biologicals, LLC Description and Business Overview
6.4.3 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product Portfolio
6.4.5 Novus Biologicals, LLC Recent Developments/Updates
6.5 Merck Group
6.5.1 Merck Group Company Information
6.5.2 Merck Group Description and Business Overview
6.5.3 Merck Group Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Group Monkeypox Virus Monoclonal Antibody Product Portfolio
6.5.5 Merck Group Recent Developments/Updates
6.6 Absolute Antibody
6.6.1 Absolute Antibody Company Information
6.6.2 Absolute Antibody Description and Business Overview
6.6.3 Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Absolute Antibody Monkeypox Virus Monoclonal Antibody Product Portfolio
6.6.5 Absolute Antibody Recent Developments/Updates
6.7 Creative Biolabs
6.7.1 Creative Biolabs Company Information
6.7.2 Creative Biolabs Description and Business Overview
6.7.3 Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Creative Biolabs Monkeypox Virus Monoclonal Antibody Product Portfolio
6.7.5 Creative Biolabs Recent Developments/Updates
6.8 Sanyoubio
6.8.1 Sanyoubio Company Information
6.8.2 Sanyoubio Description and Business Overview
6.8.3 Sanyoubio Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanyoubio Monkeypox Virus Monoclonal Antibody Product Portfolio
6.8.5 Sanyoubio Recent Developments/Updates
6.9 Cnpair
6.9.1 Cnpair Company Information
6.9.2 Cnpair Description and Business Overview
6.9.3 Cnpair Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cnpair Monkeypox Virus Monoclonal Antibody Product Portfolio
6.9.5 Cnpair Recent Developments/Updates
6.10 Vazyme
6.10.1 Vazyme Company Information
6.10.2 Vazyme Description and Business Overview
6.10.3 Vazyme Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vazyme Monkeypox Virus Monoclonal Antibody Product Portfolio
6.10.5 Vazyme Recent Developments/Updates
6.11 Sinobiological
6.11.1 Sinobiological Company Information
6.11.2 Sinobiological Description and Business Overview
6.11.3 Sinobiological Monkeypox Virus Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sinobiological Monkeypox Virus Monoclonal Antibody Product Portfolio
6.11.5 Sinobiological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monkeypox Virus Monoclonal Antibody Industry Chain Analysis
7.2 Monkeypox Virus Monoclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monkeypox Virus Monoclonal Antibody Production Mode & Process Analysis
7.4 Monkeypox Virus Monoclonal Antibody Sales and Marketing
7.4.1 Monkeypox Virus Monoclonal Antibody Sales Channels
7.4.2 Monkeypox Virus Monoclonal Antibody Distributors
7.5 Monkeypox Virus Monoclonal Antibody Customer Analysis
8 Monkeypox Virus Monoclonal Antibody Market Dynamics
8.1 Monkeypox Virus Monoclonal Antibody Industry Trends
8.2 Monkeypox Virus Monoclonal Antibody Market Drivers
8.3 Monkeypox Virus Monoclonal Antibody Market Challenges
8.4 Monkeypox Virus Monoclonal Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Monkeypox Virus Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Monkeypox Virus Monoclonal Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Monkeypox Virus Monoclonal Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Monkeypox Virus Monoclonal Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Monkeypox Virus Monoclonal Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Monkeypox Virus Monoclonal Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Monkeypox Virus Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monkeypox Virus Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Virus Monoclonal Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monkeypox Virus Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Monkeypox Virus Monoclonal Antibody Sales by Region (2020-2025) & (L)
Table 18. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Monkeypox Virus Monoclonal Antibody Sales by Region (2026-2031) & (L)
Table 20. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Monkeypox Virus Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Monkeypox Virus Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Monkeypox Virus Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) & (L)
Table 27. North America Monkeypox Virus Monoclonal Antibody Sales by Country (2026-2031) & (L)
Table 28. North America Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Monkeypox Virus Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe Monkeypox Virus Monoclonal Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Type (2020-2025)
Table 51. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Type (2026-2031)
Table 52. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Application (2020-2025)
Table 61. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Application (2026-2031)
Table 62. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2026-2031)
Table 70. ProteoGenix Company Information
Table 71. ProteoGenix Description and Business Overview
Table 72. ProteoGenix Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. ProteoGenix Monkeypox Virus Monoclonal Antibody Product
Table 74. ProteoGenix Recent Developments/Updates
Table 75. ACROBiosystems Company Information
Table 76. ACROBiosystems Description and Business Overview
Table 77. ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. ACROBiosystems Monkeypox Virus Monoclonal Antibody Product
Table 79. ACROBiosystems Recent Developments/Updates
Table 80. Creative Diagnostics Company Information
Table 81. Creative Diagnostics Description and Business Overview
Table 82. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product
Table 84. Creative Diagnostics Recent Developments/Updates
Table 85. Novus Biologicals, LLC Company Information
Table 86. Novus Biologicals, LLC Description and Business Overview
Table 87. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product
Table 89. Novus Biologicals, LLC Recent Developments/Updates
Table 90. Merck Group Company Information
Table 91. Merck Group Description and Business Overview
Table 92. Merck Group Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Merck Group Monkeypox Virus Monoclonal Antibody Product
Table 94. Merck Group Recent Developments/Updates
Table 95. Absolute Antibody Company Information
Table 96. Absolute Antibody Description and Business Overview
Table 97. Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Absolute Antibody Monkeypox Virus Monoclonal Antibody Product
Table 99. Absolute Antibody Recent Developments/Updates
Table 100. Creative Biolabs Company Information
Table 101. Creative Biolabs Description and Business Overview
Table 102. Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. Creative Biolabs Monkeypox Virus Monoclonal Antibody Product
Table 104. Creative Biolabs Recent Developments/Updates
Table 105. Sanyoubio Company Information
Table 106. Sanyoubio Description and Business Overview
Table 107. Sanyoubio Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Sanyoubio Monkeypox Virus Monoclonal Antibody Product
Table 109. Sanyoubio Recent Developments/Updates
Table 110. Cnpair Company Information
Table 111. Cnpair Description and Business Overview
Table 112. Cnpair Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Cnpair Monkeypox Virus Monoclonal Antibody Product
Table 114. Cnpair Recent Developments/Updates
Table 115. Vazyme Company Information
Table 116. Vazyme Description and Business Overview
Table 117. Vazyme Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. Vazyme Monkeypox Virus Monoclonal Antibody Product
Table 119. Vazyme Recent Developments/Updates
Table 120. Sinobiological Company Information
Table 121. Sinobiological Description and Business Overview
Table 122. Sinobiological Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Sinobiological Monkeypox Virus Monoclonal Antibody Product
Table 124. Sinobiological Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Monkeypox Virus Monoclonal Antibody Distributors List
Table 128. Monkeypox Virus Monoclonal Antibody Customers List
Table 129. Monkeypox Virus Monoclonal Antibody Market Trends
Table 130. Monkeypox Virus Monoclonal Antibody Market Drivers
Table 131. Monkeypox Virus Monoclonal Antibody Market Challenges
Table 132. Monkeypox Virus Monoclonal Antibody Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Monkeypox Virus Monoclonal Antibody
Figure 2. Global Monkeypox Virus Monoclonal Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monkeypox Virus Monoclonal Antibody Market Share by Type: 2024 & 2031
Figure 4. Purity>90% Product Picture
Figure 5. Purity>95% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Monkeypox Virus Monoclonal Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Monkeypox Virus Monoclonal Antibody Market Share by Application: 2024 & 2031
Figure 9. Diagnostic Laboratories
Figure 10. Research and Academic Laboratories
Figure 11. Pharmaceutical and Biotechnology Companies
Figure 12. Global Monkeypox Virus Monoclonal Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Monkeypox Virus Monoclonal Antibody Market Size (2020-2031) & (US$ Million)
Figure 14. Global Monkeypox Virus Monoclonal Antibody Sales (2020-2031) & (L)
Figure 15. Global Monkeypox Virus Monoclonal Antibody Average Price (US$/L) & (2020-2031)
Figure 16. Monkeypox Virus Monoclonal Antibody Report Years Considered
Figure 17. Monkeypox Virus Monoclonal Antibody Sales Share by Manufacturers in 2024
Figure 18. Global Monkeypox Virus Monoclonal Antibody Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Monkeypox Virus Monoclonal Antibody Players: Market Share by Revenue in Monkeypox Virus Monoclonal Antibody in 2024
Figure 20. Monkeypox Virus Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Monkeypox Virus Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 23. North America Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 24. United States Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 27. Europe Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 28. Germany Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2020-2031)
Figure 35. China Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 43. Latin America Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Monkeypox Virus Monoclonal Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of Monkeypox Virus Monoclonal Antibody by Type (2020-2031)
Figure 55. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2020-2031)
Figure 56. Global Sales Market Share of Monkeypox Virus Monoclonal Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of Monkeypox Virus Monoclonal Antibody by Application (2020-2031)
Figure 58. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2020-2031)
Figure 59. Monkeypox Virus Monoclonal Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
